Skip navigation
Skip navigation

Recombinant human TSH use in differentiated thyroid cancer

Graf, Hans; Da Paz Filho, Gilberto


Traditionally, the immediate treatment of patients with differentiated thyroid carcinoma (DTC) after total thyroidectomy (TT) is thyroid remnant ablation (TRA) with131I, during hypothyroidism. Late follow-up of DCT includes suppressive doses of T4, serial measurements of thyroglobulin (Tg), whole body scan (WBS) with131I and cervical ultrasound (US). In the last years, TRA with the aid of recombinant human TSH (rhTSH) has shown not only to avoid symptoms of hypothyroidism and a lower quality of...[Show more]

CollectionsANU Research Publications
Date published: 2007
Type: Journal article
Source: Arquivos Brasileiros de Endocrinologia e Metabologia


File Description SizeFormat Image
01_Graf_Recombinant_human_TSH_use_in_2007.pdf78.4 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  20 July 2017/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator